Lexpos News

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/19 Date issued: 29 April 2025 Jubilant Pharmaceuticals BV has informed the Medicines and Health products Regulatory Agency (MHRA) that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription [...]

The post MHRA Class 4 Medicines Defect Notification: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules, (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has announced that the NHS prescription charge will be kept at £9.90 per prescription item for 2025/26. A Government press release today confirms that the NHS prescription charge will be frozen, as well as the costs for prescription prepayment certificates (PPCs). PPCs offer savings for those needing multiple prescription items or [...]

The post NHS prescription charges frozen for 2025/26 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/04/2025) confirmed the following list of price concessions for April 2025.  Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £4.30 Amiodarone 200mg tablets 28 £1.99 Buprenorphine 8mg sublingual tablets sugar free 7 £9.25 Carbimazole 20mg tablets 100 £2.65 Carbimazole 5mg tablets 100 £4.63 Codeine 15mg/5ml [...]

The post April 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Ahead of making a claim for the New Medicine Service (NMS) consultations carried out in April 2025, pharmacy owners are reminded of the changes to NMS that were announced as part of the contractual settlement for 2025/26 and that came into effect from 1st April 2025. What can be claimed for? As part of the [...]

The post NMS: Making your end of month claim appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Budesonide 1mg/2ml nebuliser suspension unit dose ampoules Zentiva Pharma UK Ltd 20 unit [...]

The post 6 products re-classified as a special containers from May 2025 appeared first on Community Pharmacy England.